EANS-Adhoc: Semperit AG Holding / Record Revenues and Best Result in the Company's History in 2013 (with photo)

--------------------------------------------------------------------------------
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide
distribution. The issuer is solely responsible for the content of this
announcement.
--------------------------------------------------------------------------------

annual result/annual report
27.03.2014

- Revenue increase of 9.4% to EUR 906.3 million despite the weak
economy - Significant rise in EBITDA (+21.9%) and EBIT (+21.1%) -
Growth and enhanced profitability in both sectors - Dividend proposal
of EUR 0.90 per share (basic dividend, 2012: EUR 0.80) plus EUR 0.30
anniversary bonus - Satisfactory development expected in 2014

Vienna, March 27, 2014. - The publicly listed Semperit Group recorded
the best result in the company's history, generating record revenue
of EUR 906.3 million in 2013, up from EUR 828.6 million in 2012. In
the Medical Sector, the successful integration of the glove producer
Latexx Partners (acquired in 2012) as well as intensified sales
activities served as the basis for double-digit revenue and earnings
growth. Semperit achieved market share gains in the Industrial Sector
and substantial increases in revenue and profitability against the
backdrop of a weak market environment.

The Group's consolidated EBITDA increased by 21.9%, from EUR 108.7
million in 2012 to EUR 132.5 million. Despite the growth investments
related increase in depreciation, EBIT rose by 21.1% to EUR 87.8
million, up from the prior-year level of EUR 72.5 million. In
addition to the strong operating performance of the company, the
strategic raw material management and cost discipline played a
significant role in raising earnings. Profitability improved
accordingly. The EBITDA margin climbed from 13.1% to 14.6%
year-on-year, whereas the EBIT margin climbed to 9.7% from 8.8% in
the previous year. Semperit achieved a net result (earnings after
tax) of EUR 54.9 million, constituting an increase of 18.8% from the
comparable level of EUR 46.2 million in 2012. The Management Board
will propose the distribution of an increased basic dividend of EUR
0.90 per share (2012: EUR 0.80) to the Annual General Meeting along
with a one-time anniversary bonus of EUR 0.30 per share to
commemorate the company's 190th year of operation.

"In the face of a challenging business environment, Semperit
developed outstandingly in 2013, generating the best result in the
company's history. We pushed ahead with our strategic growth projects
in all segments and optimally managed our raw material demand", says
Semperit CEO Thomas Fahnemann in assessing the Group's performance in
2013. "In the Sempermed segment, the successful integration of Latexx
Partners and our investments in sales and marketing particularly paid
off in 2013. The consequences were double-digit volume growth in the
medical glove business and new large international customers for our
industrial gloves. In the Industrial Sector we also expanded faster
than the market in Europe and the USA, opening up new regions and
markets thanks to new products and our sales drive. Our production
capacities are well utilised. For this reason, we will invest up to
EUR 60 million in 2014 to expand our production facilities and secure
long-term growth", CEO Fahnemann adds.

Semperit continues to boast a sound capital basis as reflected by its
equity ratio of 48.3% at the reporting date (December 31, 2012:
49.3%). Cash and cash equivalents rose from EUR 133.3 million to EUR
182.6 million as a result of the strong operating cash flow
generation and the cash inflows from the Corporate Schuldschein loan.
"Semperit also features an outstanding level of financial stability
in addition to its excellent cash position. We have a positive net
liquidity of EUR 43.3 million after deducting all financial
liabilities", explains Semperit CFO Johannes Schmidt-Schultes. "The
continuation of our growth path is secured. On the basis of our
earnings and financial position, we will propose a dividend increase
to the Annual General Meeting compared to the previous year", CFO
Schmidt-Schultes adds.

Medical Sector: Substantial revenue and earnings increases In the
Medical Sector (the Sempermed segment), the integration of Latexx
Partners, an improved coordination of the company's sales efforts and
disciplined cost management resulted in a substantial rise in revenue
and earnings. Moreover, the intensified sales activities led to
significantly higher sales volumes. 31% more examination gloves were
sold in 2013 than in 2012. The ongoing negative price effects caused
by the lower raw material prices compared to 2012 were more than
offset. Capacity utilisation at the Sempermed production plants was
very good (above 80%) during the reporting period.

Revenue of the Medical Sector rose 13.4% in 2013 to EUR 434.9 million
in 2013. EBITDA was up 41.2% to EUR 58.7 million, providing an
improved EBITDA margin of 13.5% compared to 10.8% in the prior year.

Industrial Sector: Growth and high profitability despite the weak
economic conditions The Industrial Sector (the Semperflex,
Sempertrans and Semperform segments) showed a strong business
development in spite of the challenging macroeconomic environment.
New markets were opened up and market shares gained thanks to new
products and the expansion of sales activities.

The development of the Semperflex segment was characterised by sales
successes in Europe and the USA, efficient raw material procurement
and anticipating production planning. Semperflex increased its market
share for both hydraulic and industrial hoses. As a result, the
production plants operated at almost full capacity. The Sempertrans
segment generated a significant increase in earnings, primarily
driven by the strategic focus on more profitable product groups and
the enhanced internationalisation. Considerable volume growth led to
full capacity utilisation of its European production plants. The
Semperform segment also generated double-digit sales growth as well
as substantial revenue and earnings increases. All key business units
contributed to this development with higher sales volumes, which more
than compensated for the negative price effects.

Revenue of the Industrial Sector was up 5.9% in 2013 to EUR 471.5
million. EBITDA of the Industrial Sector increased by 12.4% to EUR
90.1 million, resulting in an excellent EBITDA margin of 19.1%, up
from 18.0% in the previous year. Moreover, significant double-digit
EBIT margins were generated in all segments.

Outlook 2014 and multi-year targets The Semperit Group expects a
continuation of the current good level of incoming orders and a
satisfactory development of revenue and earnings in 2014. However, no
significant growth impetus is anticipated.

The focus of the Sempermed segment will be on further enhancing the
efficiency of the individual production plants and the overall
profitability of the segment. The Semperit Group assumes that demand
for examination and protective gloves will continue to rise.

A stable development is expected in the Industrial Sector in 2014.
Due to the fact that production capacities are already being fully
utilised in the Semperflex and Sempertrans segments, Semperit decided
in 2013 to expand its capacities for hydraulic and industrial hoses
in Odry, Czech Republic and conveyor belts at the Be?chatów site in
Poland. The additional production capacities will be available in the
first half of 2015.

Semperit plans to invest about EUR 50-60 million in boosting
production capacities. Thereof EUR 25 million will be invested in the
maintenance of its existing facilities.

The Group reaffirms its previous growth target of generating
double-digit revenue growth on average in the years from 2010 to 2015
inclusive. The Semperit Group still aims to achieve an EBITDA margin
of between 12% and 15% and an EBIT margin of between 8% and 11% in
the coming years.

The annual financial report for the year 2013 is available for
download at
http://www.semperitgroup.com/en/ir/publications/annual-reports/.

About Semperit The publicly listed company Semperit AG Holding is an
internationally-oriented group that develops, produces, and sells in
more than 100 countries highly specialised rubber and plastic
products for the medical and industrial sectors: examination and
surgical gloves, hydraulic and industrial hoses, conveyor belts,
escalator handrails, construction profiles, cable car rings, and
products for railway superstructures. The headquarters of this
long-standing Austrian company, which was founded in 1824, are
located in Vienna, and the global R & D centre is in Wimpassing,
Lower Austria. The Semperit Group employs about 10,300 people
worldwide, including more than 7,000 in Asia and more than 700 in
Austria (Vienna and production site in Wimpassing, Lower Austria).
The Group has 22 manufacturing facilities worldwide and numerous
sales offices in Europe, Asia, and America.

Pictures with Announcement:
----------------------------------------------
http://resources.euroadhoc.com/us/rq4PGNoM
http://resources.euroadhoc.com/us/UtHcZ1A9

Further inquiry note:
Martina Büchele
Head of Group Communications
Tel.: +43 676 8715 8621
martina.buechele@semperitgroup.com
www.semperitgroup.com

Stefan Marin
Investor Relations
Tel.: +43 676 8715 8210
stefan.marin@semperitgroup.com

end of announcement euro adhoc
--------------------------------------------------------------------------------

Pictures with Announcement:
----------------------------------------------
http://resources.euroadhoc.com/us/rq4PGNoM
http://resources.euroadhoc.com/us/UtHcZ1A9

issuer: Semperit AG Holding
Modecenterstrasse 22
A-1030 Wien
phone: +43 1 79 777-210
FAX: +43 1 79 777-602
mail: investor@semperitgroup.com
WWW: www.semperitgroup.com
sector: Synthetics & Plastics
ISIN: AT0000785555
indexes: WBI, ATX Prime, ViDX, Prime Market, ATX Global Players
stockmarkets: official market: Wien
language: English